1
|
Taylor H: Malignant and semi-malignant
tumors of the ovary. Surg Gynecol Obstet. 48:204–230. 1929.
|
2
|
Hart WR and Norris HJ: Borderline and
malignant mucinous tumors of the ovary. Histologic criteria and
clinical behavior. Cancer. 31:1031–1045. 1973. View Article : Google Scholar : PubMed/NCBI
|
3
|
Crispens MA: Borderline ovarian tumours: a
review of the recent literature. Curr Opin Obstet Gynecol.
15:39–43. 2003. View Article : Google Scholar : PubMed/NCBI
|
4
|
Skirnisdóttir I, Garmo H, Wilander E and
Holmberg L: Borderline ovarian tumors in Sweden 1960–2005: trends
in incidence and age at diagnosis compared to ovarian cancer. Int J
Cancer. 123:1897–1901. 2008. View Article : Google Scholar
|
5
|
Sherman ME, Mink PJ, Curtis R, Cote TR,
Brooks S, Hartge P and Devesa S: Survival among women with
borderline ovarian tumors and ovarian carcinoma: a population-based
analysis. Cancer. 100:1045–1052. 2004. View Article : Google Scholar : PubMed/NCBI
|
6
|
Bostwick DG, Tazelaar HD, Ballon SC,
Hendrickson MR and Kempson RL: Ovarian epithelial tumors of
borderline malignancy. A clinical and pathologic study of 109
cases. Cancer. 58:2052–2065. 1986. View Article : Google Scholar : PubMed/NCBI
|
7
|
No authors listed. Changes in definitions
of clinical staging for carcinoma of the cervix and ovary:
International Federation of Gynecology and Obstetrics. Am J Obstet
Gynecol. 156:263–264. 1987.PubMed/NCBI
|
8
|
Serov SF, Scully RE and Solvin LH; World
Health Organization. Hisological typing of ovarian tumors.
International Histologic Classification of Tumors. World Health
Organization; Geneva: pp. 37–41. 1973
|
9
|
Benedet JL, Bender H, Jones H III, Ngan HY
and Pecorelli S: FIGO staging classifications and clinical practice
guidelines in the management of gynecologic cancers. FIGO Committee
on Gynecologic Oncology. Int J Gynaecol Obstet. 70:209–262. 2000.
View Article : Google Scholar : PubMed/NCBI
|
10
|
Morice P, Camatte S, El Hassan J, et al:
Clinical outcomes and fertility after conservative treatment of
ovarian borderline tumors. Fertil Steril. 75:92–96. 2001.
View Article : Google Scholar : PubMed/NCBI
|
11
|
Morris RT, Gershenson DM, Silva EG, et al:
Outcome and reproductive function after conservative surgery for
borderline ovarian tumors. Obstet Gynecol. 95:541–547. 2000.
View Article : Google Scholar : PubMed/NCBI
|
12
|
Tazelaar HD, Bostwick DG, Ballon SC, et
al: Conservative treatment of borderline ovarian tumors. Obstet
Gynecol. 66:417–422. 1985.PubMed/NCBI
|
13
|
Casey AC, Bell DA, Lage JM, et al:
Epithelial ovarian tumors of borderline malignancy: long-term
follow-up. Gynecol Oncol. 50:316–322. 1993. View Article : Google Scholar : PubMed/NCBI
|
14
|
Zanetta G, Rota S, Chiari S, et al:
Behavior of borderline tumors with particular interest to
persistence, recurrence, and progression to invasive carcinoma: a
prospective study. J Clin Oncol. 19:2658–2664. 2001.PubMed/NCBI
|
15
|
Chan JK, Lin YG, Loizzi V, et al:
Borderline ovarian tumors in reproductive-age women.
Fertility-sparing surgery and outcome. J Reprod Med. 48:756–760.
2003.PubMed/NCBI
|
16
|
Lenhard MS, Mitterer S, Kümper C, et al:
Long-term follow-up after ovarian borderline tumor: relapse and
survival in a large patient cohort. Eur J Obstet Gynecol Reprod
Biol. 145:189–194. 2009. View Article : Google Scholar : PubMed/NCBI
|
17
|
Morice P, Camatte S, Rey A, et al:
Prognostic factors for patients with advanced stage serous
borderline tumours of the ovary. Ann Oncol. 14:592–598. 2003.
View Article : Google Scholar : PubMed/NCBI
|
18
|
Trillsch F, Ruetzel JD, Herwig U, et al:
Surgical management and perioperative morbidity of patients with
primary borderline ovarian tumor (BOT). J Ovarian Res. 6:482013.
View Article : Google Scholar : PubMed/NCBI
|
19
|
Gotlieb WH, Soriano D, Achiron R, et al:
CA 125 measurement and ultrasonography in borderline tumors of the
ovary. Am J Obstet Gynecol. 183:541–546. 2000. View Article : Google Scholar : PubMed/NCBI
|
20
|
Prat J and De Nictolis M: Serous
borderline tumors of the ovary: a long-term follow-up study of 137
cases, including 18 with a micropapillary pattern and 20 with
microinvasion. Am J Surg Pathol. 26:1111–1128. 2002. View Article : Google Scholar : PubMed/NCBI
|
21
|
Tropé C, Kaern J, Vergote IB, Kristensen G
and Abeler V: Are borderline tumors of the ovary overtreated both
surgically and systemically? A review of four prospective
randomized trials including 253 patients with borderline tumors.
Gynecol Oncol. 51:236–243. 1993. View Article : Google Scholar : PubMed/NCBI
|